Industry

DUBLIN–(BUSINESS WIRE)–The “EU CBD Cosmetics Regulation: Updates On EU and Member State Positions” report has been added to ResearchAndMarkets.com’s offering. This report seeks to outline the substance of the discussion at the EU level about the use of CBD and other hemp ingredients in cosmetic products, gleaned from documents CBD-Intel has obtained from EU authorities … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “The 2021 US Study of Arthritis Pain Relief” report has been added to ResearchAndMarkets.com’s offering. The 2021 U.S. Study of Arthritis Pain Relief, the second in a series, is a nationally representative study exploring arthritis sufferer awareness, experience with and attitudes toward Rx and OTC oral and topical pain relievers as well as … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global HER2-Negative Breast Cancer – Pipeline Insight, 2022” drug pipelines has been added to ResearchAndMarkets.com’s offering. This “HER2-Negative Breast Cancer – Pipeline Insight, 2022” report provides comprehensive insights about 85+ companies and 85+ pipeline drugs in HER2-Negative Breast Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. … [Read more…]

The 10-point statement was coauthored by 12 prominent medical science, public health, and biomedical ethics experts from around the world HILLSDALE, Mich.–(BUSINESS WIRE)–The Academy for Science and Freedom at Hillsdale College has released a statement entitled “Ethical Principles of Public Health.” The statement, coauthored by a dozen prominent medical science, public health, and biomedical ethics … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Spinal Cord Neurostimulation Implant Market Research Report by Spinal Cord Stimulator, Lead Type, Application, End User, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Spinal Cord Neurostimulation Implant Market size was estimated at USD 3,127.32 million in 2021, USD 3,598.60 million … [Read more…]

– This marks the second indication for Pemazyre, which received accelerated FDA approval in 2020 for adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement – Pemazyre is the only FGFR inhibitor with multiple indications WILMINGTON, Del.–(BUSINESS WIRE)–Incyte (Nasdaq:INCY) today announced that … [Read more…]

Submission follows application for Omicron BA.1-adapted bivalent vaccine submitted in July If authorized, both Omicron BA.1-adapted and Omicron BA.4/BA.5-adapted bivalent vaccines will be available in the European Union as early as September NEW YORK & MAINZ, Germany–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Women’s Digital Health Market Research Report by Type (Diagnostic Tools, Mobile Apps, and Wearable Devices), Distribution Channel, Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Women’s Digital Health Market size was estimated … [Read more…]

ST. JOHN’S, Newfoundland and Labrador–(BUSINESS WIRE)–This week, the four conservative Atlantic premiers, along with Ontario’s Premier Ford, announced their idea of bringing in privatization in healthcare, instead of dealing with the recruitment and retention crisis. The premiers floated the idea of publicly funded but privately operated health care services. CUPE Newfoundland and Labrador, which represents … [Read more…]

MADRID–(BUSINESS WIRE)–The polypill developed by the CNIC and Ferrer, which includes three drugs (aspirin, an angiotensin-converting enzyme (ACE) inhibitor, and a statin), is effective at preventing secondary adverse cardiovascular events in people who have previously had a heart attack. The polypill reduces mortality from cardiovascular causes in this population by 33%. This is the finding … [Read more…]